Cyclacel Pharmaceuticals Inc. (CYCC) Fell -10.49% or -0.17 To Price $1.45 On Friday

Cyclacel Pharmaceuticals Inc. (CYCC) fell -10.49% or -0.17 to $1.45. It is around 20930 shares traded, which is 65.29% compare to the average total volume 32059. The market cap of CYCC is $17.40 million. The year to date change is -18.45%. The 52 week price range is from $1.28 to $2.27. Price of CYCC have changed 2.53% during last week. It have changed 7.33% over last month, 19.12% over last 3 months, 1.25% over last 6 months and -1.82% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYCC is 1.51. It is 4.14% above current price. The 200-day Moving Averages for CYCC is 1.58. It is 8.97% above current price. The 52-week High is 2.27. It is 56.55% from the current price. The 52-week Low is 1.28. It is -11.72% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CYCC is 7.77 on 2018-07-31. Short % to float is 2.73%. There are some statistics of CYCC. It is has market cap $17.40 million. The share outstanding is 12.00 million. The average volume is 32059. The percent of top 15 Institution holding is 25.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYCC is -94.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYCC is -73.72%.


Share this post